2025 Endocrinology Grand Rounds | Targeting Radioresistance in De-Differentiated Thyroid Cancer

Duarte, CA US
November 5, 2025

Thyroid cancer is a prevalent cancer worldwide, and has many subtypes. Radiation therapy is an advanced level of treatment in the management of thyroid cancer patients, and yet not all clinicians are familiar with this level of care for their patients with thyroid carcinoma, due to insufficient training. Additionally, radiation therapy in thyroid cancer management has become more advanced and the complexity of this treatment requires more and ongoing training.  

For many clinicians treating thyroid cancers, it is not clear when to use radiation therapy. This activity will increase the knowledge of endocrinologist to better utilize radiation therapy in their patients with thyroid carcinoma. It will also examine which radiation therapy is more useful in different cancer cases. It is imperative to be able to provide the patient that most tailored and tolerable treatment possible.  
 

Target Audience

Faculty and staff of the Department of Diabetes, Endocrinology and Metabolism, and all other healthcare providers interested in the subject matter. 

Learning Objectives

  • Identify which patients can benefit from radiation therapy.
  • Integrate radiation therapy in the management of thyroid cancer.
  • Distinguish radiation treatment modalities. 
Activity summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    City of Hope designates this 2025 Endocrinology Grand Rounds | Targeting Radioresistance in De-Differentiated Thyroid Cancer for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
Activity opens: 
11/05/2025
Activity expires: 
11/06/2025
Event starts: 
11/05/2025 - 12:30pm PST
Event ends: 
11/05/2025 - 1:30pm PST
Add to calendar: 
City of Hope
1500 E Duarte Rd
Duarte, CA 91010
United States

Virtual Meeting- Zoom

Terence M. Williams, MD, PhD   Professional Title, Institution

Presenter: Dr. Williams has indicated that there are no relevant financial relationships with ineligible companies./ OR has indicated the following relevant financial relationships: Grant/Research Support from Lunella Biotech.

Dr. Williams will be discussing the off-label or investigational use of Dabrafenib, and Tramentinb.

Planner: Pooja Manroa, MD has indicated that there are no relevant financial relationships with ineligible companies.

The educational content has been peer-reviewed, an attestation on file and no conflicts were noted.

CME Committee/Reviewer no relevant financial relationships:  Daneng Li, MD

ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: City of Hope designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

The following credit type(s) are being offered for this course:

•  AMA PRA Category 1 Credit™  1.0

The following may apply AMA PRA Category 1 Credit™ for license renewal:

Registered Nurses: Nurses may report up to 1.0 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.

Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    City of Hope designates this 2025 Endocrinology Grand Rounds | Targeting Radioresistance in De-Differentiated Thyroid Cancer for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
Please login or register to take this activity.